Mary Eileen Dolan to Receptor, ErbB-2
This is a "connection" page, showing publications Mary Eileen Dolan has written about Receptor, ErbB-2.
Connection Strength
0.035
-
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. Breast Cancer Res Treat. 2018 Feb; 168(1):207-220.
Score: 0.035